Animal studies have shown that SIRT1 activators (e.g., resveratrol) can alleviate pancreatic damage in AP models, and clinical studies reveal an inverse correlation between serum SIRT1 levels and disease severity.37, 38. This evidence concerns the gene SIRT1 and alkaline phosphatase measurement.